These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2863970)

  • 41. Pharmacodynamic studies of beta adrenergic antagonism induced in man by propranolol and practolol.
    Bodem G; Brammell HL; Weil JV; Chidsey CA
    J Clin Invest; 1973 Apr; 52(4):747-54. PubMed ID: 4144332
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Serum potassium levels and adrenergic activation.
    Kemperman CJ; Kuilman M; Njio LK
    J Clin Psychiatry; 1987 Nov; 48(11):457. PubMed ID: 3680191
    [No Abstract]   [Full Text] [Related]  

  • 43. Epinephrine-induced hypokalemia: the role of beta adrenoceptors.
    Reid JL; Whyte KF; Struthers AD
    Am J Cardiol; 1986 Apr; 57(12):23F-27F. PubMed ID: 3010693
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Heart rate and blood pressure responses to intravenous boluses of isoprenaline in the presence of propranolol, practolol and atropine.
    Arnold JM; McDevitt DG
    Br J Clin Pharmacol; 1983 Aug; 16(2):175-84. PubMed ID: 6137231
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Role of adrenergic receptors in the mechanism of action of catecholamines and DOPA on proliferative processes].
    Sukmanskiĭ OI; Arkhipenko VI; Cherkashina LP
    Biull Eksp Biol Med; 1984 Jul; 98(7):89-91. PubMed ID: 6147165
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Relative efficacy of prenalterol and pirbuterol for beta-1 adrenoceptors: measurement of agonist affinity by alteration of receptor number.
    Kenakin TP; Beek D
    J Pharmacol Exp Ther; 1984 May; 229(2):340-5. PubMed ID: 6143816
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Beta-adrenergic regulation of cyclic GMP in rat pinealocytes.
    Sugden D
    Biochem Biophys Res Commun; 1990 Mar; 167(2):835-41. PubMed ID: 1969732
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Selectivity of beta-adrenergic compounds. III - Classification of beta-receptors.
    Grana E; Lucchelli A; Zonta F
    Farmaco Sci; 1974 Oct; 29(10):786-92. PubMed ID: 4154868
    [No Abstract]   [Full Text] [Related]  

  • 49. Intrinsic sympathomimetic activity of the partial agonist prenalterol in relation to beta adrenoceptor interaction in various tissues, in vitro.
    Mattsson H; Hedberg A; Carlsson E
    J Pharmacol Exp Ther; 1983 Mar; 224(3):654-61. PubMed ID: 6131123
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Bivalent ligand type beta-adrenolytics related to practolol.
    Rampa A; Da Re P; Valenti P; Frigeni V; Sala R; Della Bella D
    Drugs Exp Clin Res; 1988; 14(9):581-6. PubMed ID: 2906585
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Cholinergic antagonism by beta-blockers. II. Sequence of interactions and final steady state effects].
    Re L; Rossini L
    Boll Soc Ital Biol Sper; 1980 May; 56(9):899-904. PubMed ID: 6108774
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Action of beta-adrenoceptor antagonists on the response to isoprenaline in the oestrogen dominated rabbit uterus.
    Nesheim BI
    Br J Pharmacol; 1975 Mar; 53(3):393-401. PubMed ID: 236797
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Beta-blockade of epinephrine-induced cyclic AMP formation in heart, liver, fat and trachea.
    Murad F
    Biochim Biophys Acta; 1973 Mar; 304(1):181-7. PubMed ID: 4144719
    [No Abstract]   [Full Text] [Related]  

  • 54. Effect of catecholamines and beta-blockers on linoleic acid desaturation activity.
    de Gómez IN; de Alaniz MJ; Brenner RR
    Lipids; 1978 Oct; 13(10):649-52. PubMed ID: 31543
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Adrenoceptor desensitization after immobilization stress or repeated injection of isoproterenol.
    Yamaguchi I; Torda T; Hirata F; Kopin IJ
    Am J Physiol; 1981 May; 240(5):H691-6. PubMed ID: 6112882
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Isoproterenol and psychopharmacological tests: antagonism by beta-adrenergic antagonists.
    Simon HF
    Pharmacol Res Commun; 1978 Mar; 10(3):211-7. PubMed ID: 28531
    [No Abstract]   [Full Text] [Related]  

  • 57. Some cardiovascular effects of timolol a new beta-adrenergic blocking agent.
    Scriabine A; Torchiana ML; Stavorski JM; Ludden CT; Minsker DH; Stone CA
    Arch Int Pharmacodyn Ther; 1973 Sep; 205(1):76-93. PubMed ID: 4148410
    [No Abstract]   [Full Text] [Related]  

  • 58. Metabolic consequences of salbutamol poisoning reversed by propranolol.
    Corea L; Bentivoglio M; Verdecchia P
    Br Med J (Clin Res Ed); 1982 Nov; 285(6354):1578. PubMed ID: 6128050
    [No Abstract]   [Full Text] [Related]  

  • 59. Beta-adrenergic potentiation of the increased in vitro accumulation of cycloleucine by rat thymocytes induced by triiodothyronine.
    Etzkorn J; Hopkins P; Gray J; Segal J; Ingbar SH
    J Clin Invest; 1979 Jun; 63(6):1172-80. PubMed ID: 36409
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical experience of a new inotropic agent--Prenalterol--in hypotension and heart failure.
    Reiz S; Waagstein F; Hjalmarson A
    Clin Cardiol; 1980 Apr; 3(2):96-105. PubMed ID: 6104553
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.